Triple Agonist Comparison Protocol
Research Panel
Metabolic Research Panel
The three most-studied incretin compounds in a single panel. Retatrutide (triple GLP-1/GIP/glucagon agonist), Semaglutide (GLP-1 baseline), and Cagrilintide (amylin analog) are frequently compared in preclinical metabolic research.
Compounds In This Panel
Catalog total (individual)$560
Panel discount (15%)−$84
Panel Price$476
All compounds shipped together with individual Certificates of Analysis.
For Research Use Only. Panel groupings reference combinations that appear in published literature. They are not intended to imply any combined biological effect. All compounds are supplied strictly for qualified laboratory research — not for human or animal consumption, diagnostic use, therapeutic use, or clinical use.
